0001640455-18-000105.txt : 20180907
0001640455-18-000105.hdr.sgml : 20180907
20180907164839
ACCESSION NUMBER: 0001640455-18-000105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180906
FILED AS OF DATE: 20180907
DATE AS OF CHANGE: 20180907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MURRAY RICHARD /CA/
CENTRAL INDEX KEY: 0001242935
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37998
FILM NUMBER: 181060609
MAIL ADDRESS:
STREET 1: 22643 WOODRIDGE CT
CITY: CUPERTINO
STATE: CA
ZIP: 95014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jounce Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640455
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 454870634
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-259-3840
MAIL ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_153635330364035.xml
FORM 4
X0306
4
2018-09-06
0
0001640455
Jounce Therapeutics, Inc.
JNCE
0001242935
MURRAY RICHARD /CA/
C/O JOUNCE THERAPEUTICS, INC.
780 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
1
1
0
0
CEO and President
Common Stock
2018-09-06
4
M
0
32000
0.48
A
32000
D
Stock Option (Right to Buy)
0.48
2018-09-06
4
M
0
32000
0
D
2024-06-26
Common Stock
32000.0
825169
D
25% of the option shares vested and became exercisable on July 14, 2015 and the remainder of the option shares vest and become exercisable in 36 monthly installments thereafter.
/s/ Anna L. Barry, Attorney-in-Fact
2018-09-07